ProKidney to Participate in TD Cowen’s 43rd Annual Health

ProKidney to Participate in TD Cowen’s 43rd Annual Health

WINSTON-SALEM, N.C., March 03, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics......

menu
menu